Decades of pathogen research have driven groundbreaking advancements, from RSV vaccines to enhanced protection against COVID-19. Explore the market potential and transformative impact of innovation in preventive medicine in this Trendline.
|
Access now for stories including:
|
-
Duchenne approval exposes FDA rift over Sarepta gene therapy
-
Accelerating advancement in gene therapy development
-
Sarepta reveals lower Elevidys sales, but points to ‘massive’ opportunity ahead
|
|
This Trendline is independently produced by our journalists. The support of our sponsors makes this journalism possible. Want to learn about sponsorship opportunities? Contact us directly at advertising@industrydive.com.
|
|
|
|
